About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

American Kidney Fund Launches National Kidney Health Equity Media Campaign

By: via GlobeNewswire

ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at bringing greater awareness of kidney disease within Black and Hispanic/Latino communities, the two groups most disproportionately affected by kidney failure in the United States.

A central piece of AKF’s Kidney Health for All™ program, this yearlong campaign focuses on prevention and disease management and will include national TV, streaming and radio PSAs, digital advertising, video in primary care doctor’s offices, and ads on billboards and public transit in metropolitan areas with high rates of kidney disease. The English and Spanish language PSAs feature Dr. Silas Norman, chair of AKF’s Board of Trustees and Co-Medical Director, Kidney and Pancreas Transplantation at the University of Michigan, and Dr. Pablo Garcia, a nephrologist and transplant nephrologist at the University of New Mexico. Garcia is also Director of the Living Donor Program and Director of the Outpatient Nephrology Clinics at the University of New Mexico.

In the U.S., the prevalence of kidney failure among Black people is more than four times that of white people, while the prevalence of kidney failure in Hispanic or Latino people is more than twice that of white people, according to the U.S. Renal Data System.

“Our message is clear: ‘We don’t just believe in Kidney Health for All – we work to achieve it,’” said LaVarne A. Burton, AKF President and CEO. “Through these awareness efforts, we hope to educate Americans, particularly those in communities where rates of end-stage kidney disease are high, that dialysis is not evitable. We are urging people to see their health care provider regularly and get their kidneys checked, so that they are empowered to prevent or slow the progression of kidney disease.”

AKF’s health equity initiative centers around four pillars:

  • Preventing and slowing the progression of kidney disease
  • Increasing diversity in clinical trials to reflect the populations the medications will treat
  • Increasing awareness and utilization of home dialysis, which can result in better outcomes, as an available treatment option
  • Increasing access and removing barriers to kidney transplantation among people of color

PSAs may be viewed on AKF’s Kidney Health for All website (KidneyHealthForAll.org) and in Spanish at Saludrenalparatodos.org.

Kidney Health for All is supported by Presenting Sponsors Boehringer Ingelheim and Eli Lilly and Company, Travere Therapeutics, Inc., and Vertex Pharmaceuticals Incorporated; Leadership Sponsors AstraZeneca and Merck; and Equity Sponsors Otsuka America Pharmaceutical, Inc. and Sanofi.

###

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nonprofit with the greatest direct impact on people with kidney disease. AKF works on behalf of 1 in 7 Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. AKF fights for kidney health for all through programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator for 21 consecutive years and the Platinum Seal of Transparency from Candid, formerly known as GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org

More News

View More
FICO’s Big Dip Could Be the Best Buying Chance of the Year
Via MarketBeat
Tickers EFX FICO
D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Via MarketBeat
Tickers QBTS RGTI
Datavault: A Speculative AI Play, But Beware of Volatility
Via MarketBeat
Topics Artificial Intelligence
Tickers DVLT IBM SCLX
Traders Are Piling Into Suncor Call Options—Should You?
Via MarketBeat
Topics World Trade
Tickers SU
Delta Air Lines Stock Looks Ready to Fly to New Highs
Via MarketBeat
Tickers DAL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.